Synopsis
No patient shall be refused admission on the ground that he/she is not able to produce a valid identity card that does not belong to the city where the hospital is located, said the ministry.
Agencies
In a significant directive to the states and Union Territories, the Union Health Ministry on Saturday said requirement of a positive COVID-19 test report is not mandatory for admission to a health facility. In its revised national policy for admission of COVID patients to various dedicated health facilities, both public and private, the Union Health Ministry said no patient will be refused services on any account, including oxygen and essential drugs, even if the he or she belongs to a different city.
The top court said in its order passed on May 6 uploaded on Saturday that the Secretary of the Union Ministry of Health and Family Welfare will be ex-officio member of the task force.
India Covid death count breaches 4K mark, cases over 4L for 4th time since May 1
It is the fourth time after May 1 that India has crossed the four-lakh-mark of new cases in last 24 hours
Saturday May 8, 2021 10:28 AM, IANS
New Delhi: India has recorded 4,187 deaths due to Covid-19 in the last 24 hours the highest so far, along with 4,01,078 fresh cases, taking the total number of cases in the country to 2,18,92,676, the Union Ministry of Health and Family Welfare said on Saturday.
It is the fourth time after May 1 that India has crossed the four-lakh-mark of new cases in last 24 hours. On Friday, India recorded 4,14,188 cases.
Prayagraj: The Prayag Chemist Association, along with Akhil Bharatiya Udhyog Vyapar Mandal, held an online meeting and urged chemists to be on high al.
Stating that over-reliance on imported drugs must be avoided, the Bombay High Court has asked the Centre and the Maharashtra government to create awareness about suitable alternatives to foreign-manufactured medicines, such as Tocilizumab, that can be used for treating COVID-19 patients. A bench of Chief Justice Dipankar Datta and Justice G S Kulkarni said that in light of the shortage of Tocilizumab, the government must tell the citizens about other locally- manufactured, cheaper, and widely-available drugs that can be used instead. The Government of India, having placed on record its stand that Itolizumab, Dexamethasone, and Methylprednisolone are equivalent and/or better than Tocilizumab, it is high time all-out efforts are made by it as well as the state to remove the incorrect public perception that has since been created that only Tocilizumab can treat the inflammatory burst conditions in COVID-19 patients, the high court said.